Crescita Therapeutics Overview
- Status
- Public
- Employees
- 68
- Stock Symbol
- CTX
- Investments
- 1
- Share Price
- $0.67
- (As of Friday Closing)
Crescita Therapeutics General Information
Description
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Personal Products
Stock Exchange
TSE
Primary Office
- 7560 Airport Road
- Unit 10
- Mississauga, Ontario L4T 4H4
- Canada
+1 (905) 000-0000
Crescita Therapeutics Timeline
Crescita Therapeutics Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.67 | $0.68 | $0.28 - $0.80 | $13.8M | 20.6M | 30.6K |
Crescita Therapeutics Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 1,949 | 8,958 | 3,903 | 2,531 |
| Revenue | 12,384 | 16,828 | 12,825 | 9,254 |
| EBITDA | 1,784 | 4,002 | 1,765 | (7,503) |
| Net Income | 108 | 1,397 | 1,848 | (8,830) |
| Total Assets | 20,762 | 20,545 | 20,238 | 17,944 |
| Total Debt | 980 | 1,185 | 3,237 | 3,431 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Crescita Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Crescita Therapeutics‘s full profile, request access.
Request a free trialCrescita Therapeutics Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Serge Verreault | Chief Executive Officer & President | ||
| Jose DaRocha | Chief Financial Officer, Finance |
Crescita Therapeutics Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 00000000000 | Self | Board Member | 000 0000 |
| 000000 00000000 | Crescita Therapeutics | Chairman & Board Member | 000 0000 |
| 0000 000000 | Self | Board Member | 000 0000 |
Crescita Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCrescita Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Crescita Therapeutics‘s full profile, request access.
Request a free trialCrescita Therapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 0000 000000 | 01-Sep-2016 | 000000000000000000 | 0000 | Pharmaceuticals | 00000 000000000 |
Crescita Therapeutics Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000 0000 000000 | Pharmaceuticals | Laval, Canada | 0000 |